1 not yet recruiting, 1 recruiting. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Not yet recruiting 1, Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Imviva Bio: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Basket Study of CTA313 in Participants With Active Autoimmune Diseases CTA313 UCAR T Cell Infusion - Systemic Lupus Erthematosus (SLE), Progressive Multiple Sclerosis (PMS) | Phase 1 | Not yet recruiting | Imviva Bio | 81 | 2026-12-01 | 2026-08-24 |
| A Study of CTD402 in T-ALL/LBL Patients CTD402 CAR T Cell Injection - Acute Lymphocytic Leukemia Refractory, Lymphoma, Lymphoblastic | Phase 1 / Phase 2 | Recruiting | Imviva Bio | 118 | 2025-10-07 | 2026-08-19 |
Autoimmune Diseases of the Nervous System (1) · Multiple Sclerosis, Chronic Progressive (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Recurrence (1)
Australia (1) · United States (1)